MARKET

NYMXF

NYMXF

Nymox Pharm
OTCPK
0.230
+0.030
+14.94%
Closed 15:06 05/22 EDT
OPEN
0.230
PREV CLOSE
0.200
HIGH
0.230
LOW
0.230
VOLUME
2.73K
TURNOVER
628
52 WEEK HIGH
1.250
52 WEEK LOW
0.120
MARKET CAP
21.45M
P/E (TTM)
-4.2910
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at NYMXF last week (0513-0517)?
Weekly Report · 2d ago
Weekly Report: what happened at NYMXF last week (0506-0510)?
Weekly Report · 05/13 11:52
Weekly Report: what happened at NYMXF last week (0429-0503)?
Weekly Report · 05/06 12:02
Weekly Report: what happened at NYMXF last week (0422-0426)?
Weekly Report · 04/29 12:09
Weekly Report: what happened at NYMXF last week (0415-0419)?
Weekly Report · 04/22 11:54
Weekly Report: what happened at NYMXF last week (0408-0412)?
Weekly Report · 04/15 11:45
Weekly Report: what happened at NYMXF last week (0401-0405)?
Weekly Report · 04/08 11:51
Weekly Report: what happened at NYMXF last week (0325-0329)?
Weekly Report · 04/01 11:47
More
About NYMXF
Nymox Pharmaceutical Corporation is a biopharmaceutical company. The Company is focused on developing its drug candidate, NX-1207, for the treatment of benign prostatic hyperplasia (BPH) and the treatment of low-grade localized prostate cancer. Its products include Fexapotide Triflutate, NicAlert and TobacAlert. Fexapotide Triflutate is a protein injectable for benign prostatic hyperplasia (prostate enlargement, BPH) and for low-grade localized prostate cancer. NicAlert is a simple test to determine smoking status. TobacAlert is a home test that provides an on-the-spot determination of a person’s level of exposure to tobacco products, including secondhand smoke. The Company’s lead drug candidate for BPH FT has completed Phase III development in more than 70 clinical centers in the United States. FT has completed a phase II trial in the United States. It has also developed the AlzheimAlert test. The Company operates in Canada, the United States and Switzerland.

Webull offers Nymox Pharmaceutical Corp stock information, including OTCPK: NYMXF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NYMXF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NYMXF stock methods without spending real money on the virtual paper trading platform.